Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07502820 Tamoxifen Citrate Drug adjuvant Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07502820 clinical trial report covering Tamoxifen Citrate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07504458 Arsenic Trioxide Acute Promyelocytic Leukemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07504458 clinical trial report covering Arsenic Trioxide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07503210 Zenagamtide Weight Loss Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07503210 clinical trial report covering Zenagamtide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20261088 ZY-A002 Cough variant asthma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
CTR20261088 clinical trial report covering ZY-A002, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
IRCT20251112067968N2 Nanocurcumin Sleep Initiation and Maintenance Disorders Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
IRCT20251112067968N2 clinical trial report covering Nanocurcumin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07505004 Vormatrigine Epilepsies, Partial Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07505004 clinical trial report covering Vormatrigine, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07505888 Group ACYW135 Meningococcal Conjugate Vaccine (Sinovac Life Sciences) Meningitis, Meningococcal Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07505888 clinical trial report covering Group ACYW135 Meningococcal Conjugate Vaccine (Sinovac Life Sciences), Phase 3, endpoints, sponsor, geography, r
Latest Hotspot
8 min read
NCT07505823 Group ACYW135 Meningococcal Conjugate Vaccine (Sinovac Life Sciences) Meningitis, Meningococcal Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07505823 clinical trial report covering Group ACYW135 Meningococcal Conjugate Vaccine (Sinovac Life Sciences), Phase 3, endpoints, sponsor, geography, r
Latest Hotspot
8 min read
NCT07505810 Group ACYW135 Meningococcal Conjugate Vaccine (Sinovac Life Sciences) Meningitis, Meningococcal Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07505810 clinical trial report covering Group ACYW135 Meningococcal Conjugate Vaccine (Sinovac Life Sciences), Phase 3, endpoints, sponsor, geography, r
Latest Hotspot
8 min read
ChiCTR2600121588 Methylprednisolone sodium succinate Acute Ischemic Stroke Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
ChiCTR2600121588 clinical trial report covering Methylprednisolone sodium succinate, Phase 3, endpoints, sponsor, geography, readout timing and development
Latest Hotspot
8 min read
NCT07506512 Misoprostol Abortion Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07506512 clinical trial report covering Misoprostol, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07509099 Cetuximab Squamous Cell Carcinoma of Head and Neck Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07509099 clinical trial report covering Cetuximab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.